Blog

Latest encapsia news

Why decentralizing clinical trials helps with patient recruitment and retention

Patient recruitment and retention can be a challenge at various points in the clinical development process. Research suggests these challenges can lead to delays of between 1 to 6 months for most clinical trials. More, 11% of clinical research sites fail to recruit any subjects, with 37% of sites missing their recruitment target to. Worldwide,… Read more »

What are the four phases of clinical trials?

Clinical trials studying and evaluating new drugs evolve through a number of different stages known as 'phases". Early phase trials examine the safety and dosing of the candidate drugs, while later phase trials are concerned more with safety, tolerability and…

How to secure quality trial data that delivers a return on investment

The clinical trial landscape has seen unprecedented advances in automated data collection. Cutting-edge technology enables the interrogation and aggregation of vast quantities of data, which brings with it significant challenges in analysis and interpretation. Drug discovery and development is a…

Raising Awareness for Breast Cancer

During the month of October, all around the globe our employees gathered to learn and help spread awareness about Breast Cancer, a disease in which 1 in 8 women will be diagnosed with in 2022.* This was a great opportunity…

Digital transformation can happen for any sponsor: How small and mid-sized biopharmaceutical companies can easily achieve digital innovation for their clinical data

In just a couple of decades, information technology has undergone a radical transformation –a sweeping evolution from floppy drives to data warehouses to data lakes. Our industry has unfortunately not ridden the arc of technology at the pace of other…

A better way to drive your digital transformation

As the ways in which clinical trials are conducted and monitored continue to modernize at pace, there is an urgent need for digital transformation in the industry. If sponsors are to realize their goals of running flexible, decentralized trials (DCT),…

Five predictions for the future of decentralized clinical trials

The message was clear from industry leaders last year – today’s clinical trials need decentralized solutions. More complexity means intensive data capture and continuous flows are essential, and vital strategic decisions rely on real-time data analysis and intelligence. Existing point…

Enabling personalized medicine through big data

It is no secret that there is a digital transformation happening across life sciences and healthcare. This seismic shift is being facilitated by cutting-edge technology that is enabling the interrogation and aggregation of the vast quantities of data that we…

Increased demand for use of encapsia in decentralized trials adds more capabilities to this revolutionary platform

Innovative technology for clinical trials is now, more than ever, necessary to deliver decentralized trials (DCT) and enable design of hybrid protocols that support trial continuity and patient-centricity. We’ve added new capabilities for encapsia, after we’ve seen increased demand for its…